Novel computational analysis of large transcriptome datasets identifies sets of genes distinguishing chronic obstructive pulmonary disease from healthy lung samples

• Published in: Scientific reports Vol. 11; no. 1; pp. 10258 - 13
• Main Authors: Roessler, Fabienne K., Benedikter, Birke J., Schmeck, Bernd, Bar, Nadav
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 13.05.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/114; 631/1647/2017/2079; 631/1647/48; 692/699/1785/4037; Chronic obstructive pulmonary disease; Computer applications; Epithelium; Gene expression; Humanities and Social Sciences; Lung diseases; Molecular modelling; multidisciplinary; Obstructive lung disease; Science; Science (multidisciplinary); Transcriptomes
• DOI: 10.1038/s41598-021-89762-8
• ISSN: 2045-2322

Chronic obstructive pulmonary disease (COPD) kills over three million people worldwide every year. Despite its high global impact, the knowledge about the underlying molecular mechanisms is still limited. In this study, we aimed to extend the available knowledge by identifying a small set of COPD-associated genes. We analysed different publicly available gene expression datasets containing whole lung tissue (WLT) and airway epithelium (AE) samples from over 400 human subjects for differentially expressed genes (DEGs). We reduced the resulting sets of 436 and 663 DEGs using a novel computational approach that utilises a random depth-first search to identify genes which improve the distinction between COPD patients and controls along the first principle component of the data. Our method identified small sets of 10 and 15 genes in the WLT and AE, respectively. These sets of genes significantly ( p  < 10 –20 ) distinguish COPD patients from controls with high fidelity. The final sets revealed novel genes like cysteine rich protein 1 (CRIP1) or secretoglobin family 3A member 2 (SCGB3A2) that may underlie fundamental molecular mechanisms of COPD in these tissues.